Poseida Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Poseida Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Poseida Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 97.4M shares, a 1.92% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 97.4M +1.84M +1.92% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 97.1M +10.2M +11.7% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 96.8M +10M +11.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 95.6M +9.67M +11.3% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 95.6M +9.63M +11.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 86.9M +24.1M +38.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 86.8M +24.1M +38.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 86M +23.4M +37.5% Dec 31, 2022 10-K 2024-03-07
Q3 2022 85.9M +23.5M +37.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 62.7M +563K +0.91% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 62.7M +578K +0.93% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 62.5M +663K +1.07% Dec 31, 2021 10-K 2023-03-09
Q3 2021 62.5M +650K +1.05% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 62.2M +48.8M +365% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 62.1M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 61.9M +48.7M +369% Dec 31, 2020 10-K 2022-03-10
Q3 2020 61.8M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 13.4M Jun 30, 2020 10-Q 2020-08-20
Q4 2019 13.2M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.